Phase I/II Study of Sorafenib In Combination With Low-Dose FP Intraarterial Infusion Chemotherapy.
Phase of Trial: Phase I/II
Latest Information Update: 24 Nov 2010
At a glance
- Drugs Sorafenib (Primary) ; Cisplatin; Fluorouracil
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms SILIUS
- 24 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jul 2009 New trial record